Our study demonstrates that METTL3, a key m6A methyltransferase, is significantly upregulated in migraine and contributes to disease progression by promoting the maturation of miR-34a-5p and regulating the Wnt1/β-catenin pathway. Here, METTL3 is linked to migraine disorder.